Patient‐reported outcomes and health‐related quality of life in effectiveness studies: pros and cons
- 1 March 2006
- journal article
- review article
- Published by Wiley in Drug Development Research
- Vol. 67 (3), 193-201
- https://doi.org/10.1002/ddr.20077
Abstract
No abstract availableKeywords
This publication has 64 references indexed in Scilit:
- Why results of clinical trials and observational studies of antitumour necrosis factor (anti-TNF) therapy differ: methodological and interpretive issuesAnnals Of The Rheumatic Diseases, 2004
- Project of Polish guidelines for conducting pharmacoeconomic evaluations in comparison to international health economic guidelinesThe European Journal of Health Economics, 2003
- Incorporating the Patient's Perspective into Drug Development and Communication: An Ad Hoc Task Force Report of the Patient-Reported Outcomes (PRO) Harmonization Group Meeting at the Food and Drug Administration, February 16, 2001Value in Health, 2003
- Impact of respiratory symptoms on health-related quality of life and medical resource utilization of patients treated by allergy specialists and primary care providersAnnals of Allergy, Asthma & Immunology, 2002
- Patient-Reported Outcomes: The Example of Health-Related Quality of Life—a European Guidance Document for the Improved Integration of Health-Related Quality of Life Assessment in the Drug Regulatory ProcessDrug Information Journal, 2002
- Prospective Study Designs in Outcomes ResearchPharmacoEconomics, 2002
- Using Health Outcomes Data to Inform Decision-MakingPharmacoEconomics, 2001
- A Comparative Review of Generic Quality-of-Life InstrumentsPharmacoEconomics, 2000
- The MOS 36-ltem Short-Form Health Survey (SF-36)Medical Care, 1992
- EuroQol - a new facility for the measurement of health-related quality of lifeHealth Policy, 1990